FDA again rejects single-dose use of AMAG's Makena

(Reuters) - AMAG Pharmaceuticals Inc said the U.S. Food and Drug Administration rejected a single dose of its hormone injection used to reduce the risk of premature birth, the agency's second rebuff in six months.